Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prevalence of sarcopenia is substantial in most geriatrics settings, but estimates vary greatly across studies because of difference in population characteristics, diagnostic criteria, and methods used to assess muscle mass, muscle strength, and physical performance. We investigated the feasibility of the European Working Group on Sarcopenia in Older People (EWGSOP) algorithm assessment in hospitalized older adults and analyzed prevalence and clinical correlates of sarcopenia. METHODS: Cross-sectional analysis of 655 participants enrolled in a multicenter observational study of older adults admitted to 12 acute hospital wards in Italy. Sarcopenia was assessed as low skeletal mass index (kg/m2) plus either low handgrip strength or low walking speed (EWGSOP criteria). Skeletal muscle mass was estimated using bioimpedance analysis. RESULTS: Of the 655 patients (age 81.0 ± 6.8 years; women 51.9%) enrolled in the study, 275 (40.2%) were not able to perform the 4-m walking test because of medical problems. The overall prevalence of sarcopenia on hospital admission was 34.7% (95% confidence interval 28-37) and it steeply increased with aging (p < .001). In multivariable analysis, patients with sarcopenia on hospital admission were older and were more likely to be male and to have congestive heart failure, cerebrovascular disease, and severe basic activities of daily living disability. The prevalence of sarcopenia was inversely correlated with body mass index. CONCLUSION: Based on EWGSOP criteria, prevalence of sarcopenia is extremely high among older adults on admission to acute hospital wards. Older age, male gender, congestive heart failure, cerebrovascular disease, severe activities of daily living disability, and body mass index were the clinical variables significantly associated with the presence of sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationAdapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 1×
“Diagnoses of specific medical conditions were gathered from the patient, attending physicians, and by a careful review of medical charts; comorbidity was assessed using the Charlson Comorbidity Index by adding scores assigned to specific discharge diagnoses (20).”
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 2×
“Sarcopenia is therefore considered a geriatric syndrome defined as a progressive impairment of muscle function due to the loss of skeletal muscle mass that occurs with advancing age (2).”
InfluentialSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 2×
“…to studies that enrolled patients admitted to specific clinical settings including in-hospital rehabilitation 3 [1, 4] 3 [2, 4.5] .336 3 [2, 5] 3 [1, 4] .639 Number of drugs, mean ± SD 6.0 ± 2.9 5.9 ± 2.8 .689 6 .0 ± 3.0 6.1 ± 2.7 .814 Notes: p values are for chi-square test or analysis of…”
InfluentialCruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Self-citationMuscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732 · cited 1×
“Finally, we were not able to formally differentiate cases of sarcopenia from cases of cachexia, a condition highly prevalent in the acute care wards (37).”
Self-citationEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“On the other hand, although sarcopenia often coexists with elevated BMI, a condition referred to as sarcopenic obesity (24), it has been demonstrated that compared to normal weight individuals, obese subjects have greater thigh muscle volume, increased cross-sectional area of type I skeletal muscle…”
Self-citationRole of muscle mass and muscle quality in the association between diabetes and gait speed
Volpato, S., Bianchi, L., Lauretani, F., Lauretani, F., Bandinelli, S., Guralnik, J. M., Zuliani, G., & Ferrucci, L. (2012) · Diabetes Care · doi:10.2337/dc11-2202 · Cited by 294 · cited 1×
“…referred to as sarcopenic obesity (24), it has been demonstrated that compared to normal weight individuals, obese subjects have greater thigh muscle volume, increased cross-sectional area of type I skeletal muscle fibers, increased muscle lipid content (25), and a lower muscle quality (26).”
Self-citation
Cited by
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Arai, H., Kritchevsky, S. B., Guralnik, J., Bauer, J. M., Pahor, M., Clark, B. C., Cesari, M., et al. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1139-9 · Cited by 1,130
Self-citationTicinesi, A., Lauretani, F., Milani, C., Nouvenne, A., Tana, C., Del Rio, D., Maggio, M., Ventura, M., & Meschi, T. (2017) · Nutrients · doi:10.3390/nu9121303 · Cited by 401
“Interestingly, sarcopenia can represent both a risk factor for hospitalization, since it is highly prevalent in older patients admitted to hospitals [2], and an adverse event of hospitalization itself, particularly when the stay is prolonged and characterized by forced bed rest [18].”
BackgroundSelf-citationApproaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review
Amini, B., Boyle, S. P., Boutin, R. D., & Lenchik, L. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz034 · Cited by 391
Vitamin D Deficiency and Sarcopenia in Older Persons
Remelli, F., Vitali, A., Zurlo, A., & Volpato, S. (2019) · Nutrients · doi:10.3390/nu11122861 · Cited by 348
Self-citationPapadopoulou, S. K., Tsintavis, P., Potsaki, G., & Papandreou, D. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-019-1267-x · Cited by 321
Metadata
- Authors
- Bianchi, L., Abete, P., Bellelli, G., Bo, M., Cherubini, A., Corica, F., Di Bari, M., Maggio, M., Manca, G. M., Rizzo, M. R., Rossi, A. P., Landi, F., Volpato, S., & for the GLISTEN Group Investigators
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-21
- Volume
- 72
- Issue
- 11
- Pages
- 1575-1581
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2588042958
- Cited by
- 135
- References
- 11
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study. https://app.cochat.ai/papers/10.1093/gerona/glw343
- The paper
- Bianchi, L., Abete, P., Bellelli, G., Bo, M., Cherubini, A., Corica, F., Di Bari, M., Maggio, M., Manca, G. M., Rizzo, M. R., Rossi, A. P., Landi, F., Volpato, S., & for the GLISTEN Group Investigators. (2017). Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glw343
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.